Clinical Trial Update: A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial evaluating Encorafenib, Binimetinib, and Pembrolizumab in advanced or metastatic melanoma. The study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Binimetinib (Mektovi) (binimetinib)
• Encorafenib (Braftovi) (encorafenib)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Pfizer | Conditions: Melanoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING